Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
T.PYR: Contract Toward Titanium Powder Supply & Distribution Agreement with Asian Materials Co. (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Biomarin Pharmaceutical Inc BMRN

Healthcare Biotechnology
BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally. The company’s products include VIMIZIM, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV... see more

Current News (NDAQ:BMRN)

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Clearwater Analytics Holdings, Inc. (NYSE - CWAN), Katapult Holdings, Inc. (Nasdaq - KPLT), Janus Henderson Group plc (NYSE - JHG), Amicus Therapeutics, Inc. (Nasdaq - FOLD)

GlobeNewswire December 23, 2025

BioMarin to Participate at the Jefferies Global Healthcare Conference on Tuesday, November 18, 2025, at 10:30 AM GMT in London, England

PR Newswire November 11, 2025

FDA Accepts BioMarin's PALYNZIQ® (pegvaliase-pqpz) Supplemental Biologics License Application for Priority Review to Expand Use to Adolescents Aged 12-17 with Phenylketonuria

PR Newswire October 29, 2025

BioMarin Reports Third Quarter 2025 Results and Provides Corporate Update

PR Newswire October 27, 2025

BioMarin to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Monday, October 27, 2025, at 4:30pm ET

PR Newswire October 22, 2025

BioMarin Shares New Data Reinforcing Its Leadership in Bone Health at the American Society for Bone and Mineral Research Annual Meeting

PR Newswire September 8, 2025

BioMarin Announces Positive Pivotal Phase 3 Data for PALYNZIQ® (pegvaliase-pqpz) in Adolescents with Phenylketonuria at 15th International Congress of Inborn Errors of Metabolism

PR Newswire September 6, 2025

BioMarin to Participate in Upcoming Investor Conferences

PR Newswire August 27, 2025

BioMarin Reports Strong Second Quarter 2025 Results and Raises Full-year Guidance¹ for Total Revenues, Non-GAAP Operating Margin, and Non-GAAP Diluted EPS

PR Newswire August 4, 2025
View More News ››

Opinion & Analysis (NDAQ:BMRN)

How sick will Brexit make biotech and pharma?

The Life Sciences Report June 29, 2016

The Calandra Report: Watch this hot tub!

Thom Calandra January 10, 2014

Big Pharma has a big problem and merger mania is heating up

Marc Lichtenfeld July 29, 2010
View More Opinion ››

Bullboard Posts (NDAQ:BMRN)

$15 billion biotech stock

there's clearly a wind at the back of this health care company. As a biotech stock that focuses on rare disease gene therapy, BMRN is...
Lisaslab - August 24, 2022

Bulls on Parade

Get ready for the correction; getting close to day 3 
hart.marco - August 21, 2020

Holding Strong

in the face of overall weakness.strong management leads to strong results.great job here!...again,if this was a vancouver,canada bio-tech...
seldomseen1 - March 7, 2008

RE: moving forward

new highs ..here we come.if this was a vancouver biotech(LOL)/managements there would roll this back..they are too funny LOL.
seldomseen1 - February 1, 2008

moving forward

coming off highs,still very strong going forward.
seldomseen1 - January 29, 2008

Coming of HIGHS

but what a run.if this was a VANCOUVER bio-tech..managment would have rolled the stock back LOL.Biomarin.nice work.
seldomseen1 - January 23, 2008
View more Bullboard ››

Deep Sea Minerals Corp.

Deep Sea Minerals Corp.

Deep Sea Minerals Corp. engages in the exploration and development of deep-sea critical minerals for energy security, defense ...
View More »

Podcasts